🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Phillip M. Rappold

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-2977-1023
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058
Top 20%
1.0DataRank
Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Papers

Driven by 5 papers — median percentile 80. Top paper: “Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma”.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058
Top 20%
1.0DataRank
Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

European Urology Focus(2022)10.1016/j.euf.2021.12.002
N/A
0.835DataRank · unranked
27 citations

Cerise Tang, Mark Zucker, Kelly N. Fitzgerald, Renzo G. DiNatale, Phillip M. Rappold +15 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925
N/A
0DataRank · unranked
33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.013
N/A
0DataRank · unranked
6 citations

Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram, Phillip M. Rappold +7 more

Intratumoral early activated TCF1+ CD4 Th cells drive effector CD8 T cell responses in a novel sarcomatoid RCC model through anti-CTLA4 therapy 3951

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1692
N/A
0DataRank · unranked
0 citations

Lynda Vuong, Fengshen Kuo, Doris Zheng, Alex Penson, Jing Zhang +15 more